Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9806	Companies
196689	Keywords
127705	Articles
104572	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 09/29/2025 at 06:05, 4 months 6 days ago

Onco-Innovations and Nucro-Technics Initiate Preclinical PNKP Program

Preclinical Studies Onco-Innovations PNKP Technology Nucro-Technics Analytical Development
PRESS RELEASE

published on 09/29/2025 at 06:00, 4 months 6 days ago

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
Onco-Innovations collaborates with Nucro-Technics for preclinical drug development services focusing on PNKP Technology. Nucro-Technics initiates lab work under IND enabling program with advanced analytical methods based on LC-MS

Preclinical Onco-Innovations PNKP Technology Nucro-Technics Analytical Methods
BRIEF

published on 09/22/2025 at 23:05, 4 months 12 days ago

Onco-Innovations nomme le Dr Michael Lock au conseil consultatif

Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Dr Michael Lock Conseil Consultatif Clinique
BRIEF

published on 09/22/2025 at 23:05, 4 months 12 days ago

Onco-Innovations Appoints Dr. Michael Lock to Advisory Board

Cancer Research Onco-Innovations PNKP Inhibitor Clinical Advisory Board Dr. Michael Lock
PRESS RELEASE

published on 09/22/2025 at 23:00, 4 months 12 days ago

Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
Onco-Innovations appoints Dr. Michael Lock, an expert in oncology and clinical trial design, to its Advisory Board. The company also grants RSUs to key personnel

Cancer Research RSUs Onco-Innovations Dr. Michael Lock Clinical Trial Design
BRIEF

published on 09/20/2025 at 00:05, 4 months 15 days ago

Onco-Innovations Initiates Nanoparticle Manufacturing with Dalton Pharma

Cancer Treatment Preclinical Studies Nanoparticle Manufacturing Onco-Innovations Dalton Pharma
BRIEF

published on 09/20/2025 at 00:05, 4 months 15 days ago

Onco-Innovations lance la fabrication de nanoparticules avec Dalton Pharma

Traitement Du Cancer Etudes Précliniques Fabrication De Nanoparticules Onco-Innovations Dalton Pharma
PRESS RELEASE

published on 09/20/2025 at 00:00, 4 months 15 days ago

Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies
Onco-Innovations announces manufacturing of nanoparticle formulation by Dalton Pharma Services to advance preclinical studies, enhancing clinical readiness in cancer research

Cancer Research Preclinical Studies Onco-Innovations Nanoparticle Formulation Dalton Pharma Services
BRIEF

published on 09/13/2025 at 00:05, 4 months 22 days ago

Onco-Innovations to Lead Key Oncology Forum on Precision Medicine

Oncology Precision Medicine Digital Trust AI In Healthcare Data Innovation
BRIEF

published on 09/13/2025 at 00:05, 4 months 22 days ago

Onco-Innovations animera un forum clé sur l'oncologie et la médecine de précision

Oncologie Confiance Numérique Médecine De Précision L'IA Dans Le Secteur De La Santé Innovation En Matière De Données

Accesswire

Published on 02/05/2026 at 01:35, 7 hours 26 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 9 hours 1 minute ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 10 hours 36 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 15 hours 1 minute ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 16 hours 46 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 08:35, 25 minutes ago

EQS-Adhoc: Westwing Group SE: Cancellation of Treasury Shares and Share Buyback
Published on 02/05/2026 at 08:30, 31 minutes ago

Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism
Published on 02/05/2026 at 08:05, 55 minutes ago

OPEC Fund marks 50ᵗʰ anniversary with record US$3.2 billion in development financing
Published on 02/05/2026 at 08:00, 1 hour 1 minute ago

Custodian Property Income REIT plc: Disposal of Glasgow Offices at a 24% Premium to Valuation
Published on 02/05/2026 at 08:00, 1 hour 1 minute ago

Transaction in Own Shares

Les Echos

Published on 02/04/2026 at 18:04, 14 hours 56 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 14 hours 56 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 15 hours 16 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 15 hours 16 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 15 hours 16 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE